BDBM738009 4-cyclopropyl-7-(2-((2- cyclopropyl-4-(1- (cyclopropylmethyl)piperidin-4- yl)phenyl)amino)-5- (trifluoromethyl)pyrimidin-4-yl)- 3,4-dihydrothieno[2,3- f][1,4]thiazepin-5(2H)-one 1,1- dioxide::US20250144094, Example 241

SMILES O=C1c2sc(-c3nc(Nc4ccc(C5CCN(CC6CC6)CC5)cc4C4CC4)ncc3C(F)(F)F)cc2S(=O)(=O)CCN1C1CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 738009   

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM738009(4-cyclopropyl-7-(2-((2- cyclopropyl-4-(1- (cyclopr...)
Affinity DataIC50: 5nMAssay Description:Table 4: ULK1 inhibitor potency was determined using the luminescent ADP Glo Kinase Assay (Promega), a universal ADP detection system that measures k...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent